Zymography methods for visualizing hydrolytic enzymes

Nature Methods

Volumn 10, Issue 3, 2013, Pages 211-220

  Vandooren, Jennifer ^a   Geurts, Nathalie ^a   Martens, Erik ^a   Van Den Steen, Philippe E ^a   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DYSTROGLYCAN; ENZYME INHIBITOR; GELATINASE A; GELATINASE B; HYDROLASE; MATRILYSIN; PLASMINOGEN ACTIVATOR; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANTIBODY ZYMOGRAPHY; CASEOGRAM PRINT; CRITICAL MICELLE CONCENTRATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; IN GEL ZYMOGRAPHY; IN SITU ZYMOGRAPHY; IN VIVO ZYMOGRAPHY; MICROFLUIDIC GRADIENT GEL ZYMOGRAPHY; MIXED SUBSTRATE ZYMOGRAPHY; MOLECULAR WEIGHT; MULTIPLE LAYER ZYMOGRAPHY; OPTICAL ZYMOGRAPHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REAL TIME ZYMOGRAPHY; REVIEW; SYNTHESIS ACTIVITY BASED ZYMOGRAPHY; TISSUE SECTION; TRANSFER ZYMOGRAPHY; TUMOR MICROENVIRONMENT; WHOLE BODY IMAGING; ZYMOGRAPHY;

ANIMALS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENT DYES; HUMANS; HYDROLYSIS; MICROSCOPY, FLUORESCENCE; MOLECULAR PROBES; MOLECULAR WEIGHT; PEPTIDE HYDROLASES; SUBSTRATE SPECIFICITY;

EID: 84874626363     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.2371     Document Type: Review

References (75)

1. Gross, J. & Lapière, C.M. Collagenolytic activity in amphibian tissues: A tissue culture assay. Proc. Natl. Acad. Sci. USA 48, 1014-1022 (1962).
2. Granelli-Piperno, A. & Reich, E. A study of proteases and protease-inhibitor complexes in biological fluids. J. Exp. Med. 148, 223-234 (1978).
3. Heussen, C. & Dowdle, E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102, 196-202 (1980).
4. Hibbs, M.S., Hasty, K.A., Seyer, J.M., Kang, A.H. & Mainardi, C.L. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260, 2493-2500 (1985).
5. Masure, S., Billiau, A., Van Damme, J. & Opdenakker, G. Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate. Biochim. Biophys. Acta 1054, 317-325 (1990).
6. Masure, S., Proost, P., Van Damme, J. & Opdenakker, G. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur. J. Biochem. 198, 391-398 (1991).
7. Houde, M. et al. Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cells. Int. J. Cancer 53, 395-400 (1993).
8. Paemen, L. et al. The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. Biochem. Pharmacol. 52, 105-111 (1996).
9. Van den Steen, P.E. et al. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37, 375-536 (2002).
10. Galis, Z.S., Sukhova, G.K., Lark, M.W. & Libby, P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94, 2493-2503 (1994).
11. Galis, Z.S., Sukhova, G.K. & Libby, P. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J. 9, 974-980 (1995).
12. Kaijzel, E.L., van der Pluijm, G. & Lowik, C.W. Whole-body optical imaging in animal models to assess cancer development and progression. Clin. Cancer Res. 13, 3490-3497 (2007).
13. Weissleder, R., Tung, C.H., Mahmood, U. & Bogdanov, A. Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375-378 (1999).
14. Bremer, C., Tung, C.H. & Weissleder, R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat. Med. 7, 743-748 (2001).
15. Crawford, B.D. & Pilgrim, D.B. Ontogeny and regulation of matrix metalloproteinase activity in the zebrafish embryo by in vitro and in vivo zymography. Dev. Biol. 286, 405-414 (2005).
16. Kleiner, D.E. & Stetler-Stevenson, W.G. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218, 325-329 (1994).
17. Kupai, K. et al. Matrix metalloproteinase activity assays: importance of zymography. J. Pharmacol. Toxicol. Methods 61, 205-209 (2010).
18. Ikeda, M. et al. Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: Application of film in situ zymography. Clin. Cancer Res. 6, 3290-3296 (2000).
19. Wilkesman, J. & Kurz, L. Protease analysis by zymography: A review on techniques and patents. Recent Pat. Biotechnol. 3, 175-184 (2009).
20. Vandooren, J. et al. Gelatin degradation assay reveals MMP-9 inhibitors and function of O-glycosylated domain. World J. Biol. Chem. 2, 14-24 (2011).
21. McKerrow, J.H., Pino-Heiss, S., Lindquist, R. & Werb, Z. Purification and characterization of an elastinolytic proteinase secreted by cercariae of Schistosoma mansoni. J. Biol. Chem. 260, 3703-3707 (1985).
22. Baragi, V.M. et al. A versatile assay for gelatinases using succinylated gelatin. Matrix Biol. 19, 267-273 (2000).
23. Lê, J. et al. Quantitative zymography of matrix metalloproteinases by measuring hydroxyproline: Application to gelatinases A and B. Electrophoresis 20, 2824-2829 (1999).
24. Liabakk, N.B., Talbot, I., Smith, R.A., Wilkinson, K. & Balkwill, F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 56, 190-196 (1996).
25. Curino, A. et al. Detection of plasminogen activators in oral cancer by laser capture microdissection combined with zymography. Oral Oncol. 40, 1026-1032 (2004).
26. Margulies, I.M. et al. Urinary type IV collagenase: Elevated levels are associated with bladder transitional cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 1, 467-474 (1992).
27. Li, L. et al. Inhibitory effects of GL-V9 on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-2/9. Eur. J. Pharm. Sci. 43, 393-399 (2011).
28. Wang, Z. et al. Interleukin-lβ induces migration of rat arterial smooth muscle cells through a mechanism involving increased matrix metalloproteinase-2 activity. J. Surg. Res. 169, 328-336 (2011).
29. Tamura, Y. et al. Profibrinolytic effect of Enzamin, an extract of metabolic products from Bacillus subtilis AK and Lactobacillus. J. Thromb. Thrombolysis 32, 195-200 (2011).
30. Fontana, V. et al. Consistent alterations of circulating matrix metalloproteinases levels in untreated hypertensives and in spontaneously hypertensive rats: A relevant pharmacological target. Basic Clin. Pharmacol. Toxicol. 109, 130-137 (2011).
31. Knier, B. et al. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage. J. Hypertens. 29, 1602-1612 (2011).
32. Todorova, L., Bjermer, L., Westergren-Thorsson, G. & Miller-Larsson, A. TGFβ-induced matrix production by bronchial fibroblasts in asthma: Budesonide and formoterol effects. Respir. Med. 105, 1296-1307 (2011).
33. Huang, C.Y. et al. Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes. Rheumatology (Oxford) 50, 1379-1389 (2011).
34. Paemen, L., Olsson, T., Söderström, M., van Damme, J. & Opdenakker, G. Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases. Eur. J. Neurol. 1, 55-63 (1994).
35. Rossano, R., Larocca, M. & Riccio, P. 2-D zymographic analysis of Broccoli (Brassica oleracea L. var. Italica) florets proteases: Follow up of cysteine protease isotypes in the course of post-harvest senescence. J. Plant Physiol. 168, 1517-1525 (2011).
36. Geib, S.M., Tien, M. & Hoover, K. Identification of proteins involved in lignocellulose degradation using in gel zymogram analysis combined with mass spectroscopy-based peptide analysis of gut proteins from larval Asian longhorned beetles, Anoplophora glabripennis. Insect Sci. 17, 253-264 (2010).
37. Velada, I. et al. Expression of genes encoding extracellular matrix macromolecules and metalloproteinases in avian tibial dyschondroplasia. J. Comp. Pathol. 145, 174-186 (2011).
38. Métayer, S., Dacheux, F., Dacheux, J.L. & Gatti, J.L. Comparison, characterization, and identification of proteases and protease inhibitors in epididymal fluids of domestic mammals. Matrix metalloproteinases are major fluid gelatinases. Biol. Reprod. 66, 1219-1229 (2002).
39. Kim, S.H., Choi, N.S. & Lee, W.Y. Fibrin zymography: A direct analysis of fibrinolytic enzymes on gels. Anal. Biochem. 263, 115-116 (1998).
40. Park, S.G. et al. A functional proteomic analysis of secreted fibrinolytic enzymes from Bacillus subtilis 168 using a combined method of two-dimensional gel electrophoresis and zymography. Proteomics 2, 206-211 (2002).
41. Hasson, S.S., Theakston, R.D. & Harrison, R.A. Antibody zymography: A novel adaptation of zymography to determine the protease-neutralising potential of specific antibodies and snake antivenoms. J. Immunol. Methods 292, 131-139 (2004).
42. Hughes, A.J. & Herr, A.E. Quantitative enzyme activity determination with zeptomole sensitivity by microfluidic gradient-gel zymography. Anal. Chem. 82, 3803-3811 (2010).
43. Thimon, V., Belghazi, M., Labas, V., Dacheux, J.L. & Gatti, J.L. One- and two-dimensional SDS-PAGE zymography with quenched fluorogenic substrates provides identification of biological fluid proteases by direct mass spectrometry. Anal. Biochem. 375, 382-384 (2008).
44. Pan, D., Hill, A.P., Kashou, A., Wilson, K.A. & Tan-Wilson, A. Electrophoretic transfer protein zymography. Anal. Biochem. 411, 277-283 (2011).
45. Choi, N.S. et al. Mixed-substrate (glycerol tributyrate and fibrin) zymography for simultaneous detection of lipolytic and proteolytic enzymes on a single gel. Electrophoresis 30, 2234-2237 (2009).
46. Choi, N.S. et al. Multiple-layer substrate zymography for detection of several enzymes in a single sodium dodecyl sulfate gel. Anal. Biochem. 386, 121-122 (2009).
47. Oliver, G.W., Leferson, J.D., Stetler-Stevenson, W.G. & Kleiner, D.E. Quantitative reverse zymography: Analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal. Biochem. 244, 161-166 (1997).
48. Yan, S.J. & Blomme, E.A. In situ zymography: A molecular pathology technique to localize endogenous protease activity in tissue sections. Vet. Pathol. 40, 227-236 (2003).
49. Duran-Vilaregut, J. et al. Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease. Neuropathol. Appl. Neurobiol. 37, 525-537 (2011).
50. Mungall, B.A. & Pollitt, C.C. In situ zymography: Topographical considerations. J. Biochem. Biophys. Methods 47, 169-176 (2001).
51. Hu, J., Van den Steen, P.E., Sang, Q.X. & Opdenakker, G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug Discov. 6, 480-498 (2007).
52. Van den Steen, P.E. et al. Matrix metalloproteinases, tissue inhibitors of MMPs and TACE in experimental cerebral malaria. Lab. Invest. 86, 873-888 (2006).
53. Redondo-Muñoz, J. et al. Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia B cell survival through its hemopexin domain. Cancer Cell 17, 160-172 (2010).
54. Agrawal, S. et al. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J. Exp. Med. 203, 1007-1019 (2006).
55. Louboutin, J.P., Agrawal, L., Reyes, B.A., Van Bockstaele, E.J. & Strayer, D.S. HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress. J. Neuropathol. Exp. Neurol. 69, 801-816 (2010).
56. Oh, L.Y. et al. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J. Neurosci. 19, 8464-8475 (1999).
57. Wyatt, R.A. et al. The zebrafish embryo: A powerful model system for investigating matrix remodeling. Zebrafish 6, 347-354 (2009).
58. Keow, J.Y., Herrmann, K.M. & Crawford, B.D. Differential in vivo zymography: A method for observing matrix metalloproteinase activity in the zebrafish embryo. Matrix Biol. 30, 169-177 (2011).
59. Scherer, R.L., VanSaun, M.N., McIntyre, J.O. & Matrisian, L.M. Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Mol. Imaging 7, 118-131 (2008).
60. Saghatelian, A., Jessani, N., Joseph, A., Humphrey, M. & Cravatt, B.F. Activity-based probes for the proteomic profiling of metalloproteases. Proc. Natl. Acad. Sci. USA 101, 10000-10005 (2004).
61. Keow, J.Y., Pond, E.D., Cisar, J.S., Cravatt, B.F. & Crawford, B.D. Activity-based labeling of matrix metalloproteinases in living vertebrate embryos. PLoS ONE 7, e43434 (2012).
62. Smith, C. Keeping tabs on fluorescent tags. Nat. Methods 4, 755-761 (2007).
63. López-Otín, C. & Overall, C.M. Protease degradomics: A new challenge for proteomics. Nat. Rev. Mol. Cell Biol. 3, 509-519 (2002).
64. Overall, C.M. et al. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Biol. Chem. 385, 493-504 (2004).
65. Schilling, O. & Overall, C.M. Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat. Biotechnol. 26, 685-694 (2008).
66. Dean, R.A. & Overall, C.M. Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Mol. Cell Proteomics 6, 611-623 (2007).
67. Cauwe, B. & Opdenakker, G. Intracellular substrate cleavage: A novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol. 45, 351-423 (2010).
68. Tsiatsiani, L., Gevaert, K. & Van Breusegem, F. Natural substrates of plant proteases: how can protease degradomics extend our knowledge? Physiol. Plant. 145, 28-40 (2012).
69. Piccard, H. et al. "Reverse degradomics", monitoring of proteolytic trimming by multi-CE and confocal detection of fluorescent substrates and reaction products. Electrophoresis 30, 2366-2377 (2009).
70. Kaberdin, V.R. & McDowall, K.J. Expanding the use of zymography by the chemical linkage of small, defined substrates to the gel matrix. Genome Res. 13, 1961-1965 (2003).
71. Foltmann, B., Szecsi, P.B. & Tarasova, N.I. Detection of proteases by clotting of casein after gel electrophoresis. Anal. Biochem. 146, 353-360 (1985).
72. Till, O., Baumann, E. & Linss, W. Zymography with caseogram prints: quantification of pepsinogen. Anal. Biochem. 292, 22-25 (2001).
73. Kwon, M.A., Kim, H.S., Hahm, D.H. & Song, J.K. Synthesis activity-based zymography for detection of lipases and esterases. Biotechnol. Lett. 33, 741-746 (2011).
74. Law, B., Hsiao, J.K., Bugge, T.H., Weissleder, R. & Tung, C.H. Optical zymography for specific detection of urokinase plasminogen activator activity in biological samples. Anal. Biochem. 338, 151-158 (2005).
75. Hattori, S., Fujisaki, H., Kiriyama, T., Yokoyama, T. & Irie, S. Real-time zymography and reverse zymography: A method for detecting activities of matrix metalloproteinases and their inhibitors using FITC-labeled collagen and casein as substrates. Anal. Biochem. 301, 27-34 (2002).